A Prospective Non-interventional Real-World Study of cabozantinib in Pretreated Patients With Advanced Renal Cell Carcinoma Refractory to Vascular Endothelial Growth Factor-Targeted Therapy (CASSIOPE).
Staehler M, Basso U, Eymard JC, Barthelemy P, Bigot P, Laramas M, Rink M, Suarez C, Guillot A, Bedke J, Hamberg P, De Vivo R, Gajate P, Lázaro-Quintela M, Rastogi P, Perrot V, Qvick B, Dutailly P, Verzoni E, Procopio G.
Staehler M, et al. Among authors: dutailly p.
Clin Genitourin Cancer. 2024 Nov 30;23(1):102285. doi: 10.1016/j.clgc.2024.102285. Online ahead of print.
Clin Genitourin Cancer. 2024.
PMID: 39740313
Free article.